A New Era: Tumor Microenvironment in Chemoresistance of Pancreatic Cancer
Journal of Cancer Science and Clinical Therapeutics · 2022 · 06 (01)
DOI: 10.26502/jcsct.5079146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Science and Clinical Therapeutics, 2022. Verfasst von Xueping Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Biopharmaceutical, Shenyang Pharmaceutical University, Shenyang, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a solid malignant tumor with an extremely poor prognosis. Gemcitabine (GEM)-based chemotherapy remains one of the most important treatment choices for PDAC. However, either as monotherapy or as a part of the combination chemotherapy, GEM achieved only limited success in improving the survival of patients with advanced PDAC, primarily due to GEM resistance. PDAC is characterized by an extensive desmoplasia in the tumor microenvironment (TME). Increasing evidence indicates that this fibrotic TME not only actively participates in the tumor growth and spread of PDAC but also contributes to the induction of GEM resistance. Here we review the current advances of how TME components are involved in the induction of GEM resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science and Biopharmaceutical, Shenyang Pharmaceutical University, Shenyang, China.
- Department of Pancreatic and Gastric Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Zhao, X., Li, Z., & Gu, Z. (2022). A New Era: Tumor Microenvironment in Chemoresistance of Pancreatic Cancer. Journal of Cancer Science and Clinical Therapeutics, 06(01). https://doi.org/10.26502/jcsct.5079146
Vancouver
Zhao X, Li Z, Gu Z. A New Era: Tumor Microenvironment in Chemoresistance of Pancreatic Cancer. Journal of Cancer Science and Clinical Therapeutics. 2022;06(01). doi:10.26502/jcsct.5079146
BibTeX
@article{Zhao2022,
author = {Zhao, Xueping and Li, Zongze and Gu, Zongting},
title = {A New Era: Tumor Microenvironment in Chemoresistance of Pancreatic Cancer},
journal = {Journal of Cancer Science and Clinical Therapeutics},
year = {2022},
volume = {06},
number = {01},
doi = {10.26502/jcsct.5079146}
}
EUVIMED